Analysis of cellularity in H&E-stained rat bone marrow tissue via deep learning

• Main Authors: Smadar Shiffman (Author), Edgar A. Rios Piedra (Author), Adeyemi O. Adedeji (Author), Catherine F. Ruff (Author), Rachel N. Andrews (Author), Paula Katavolos (Author), Evan Liu (Author), Ashley Forster (Author), Jochen Brumm (Author), Reina N. Fuji (Author), Ruth Sullivan (Author)
• Format: Book
• Published: Elsevier, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 2153-3539; 10.1016/j.jpi.2023.100333
• Keywords: Cell quantification; Deep learning; Digital pathology; H&E rat bone marrow; Computer applications to medicine. Medical informatics; R858-859.7; Pathology; RB1-214
• Source: Journal of Pathology Informatics, Vol 14, Iss , Pp 100333- (2023)

Our objective was to develop an automated deep-learning-based method to evaluate cellularity in rat bone marrow hematoxylin and eosin whole slide images for preclinical safety assessment. We trained a shallow CNN for segmenting marrow, 2 Mask R-CNN models for segmenting megakaryocytes (MKCs), and small hematopoietic cells (SHCs), and a SegNet model for segmenting red blood cells. We incorporated the models into a pipeline that identifies and counts MKCs and SHCs in rat bone marrow. We compared cell segmentation and counts that our method generated to those that pathologists generated on 10 slides with a range of cell depletion levels from 10 studies. For SHCs, we compared cell counts that our method generated to counts generated by Cellpose and Stardist. The median Dice and object Dice scores for MKCs using our method vs pathologist consensus and the inter- and intra-pathologist variation were comparable, with overlapping first-third quartile ranges. For SHCs, the median scores were close, with first-third quartile ranges partially overlapping intra-pathologist variation. For SHCs, in comparison to Cellpose and Stardist, counts from our method were closer to pathologist counts, with a smaller 95% limits of agreement range. The performance of the bone marrow analysis pipeline supports its incorporation into routine use as an aid for hematotoxicity assessment by pathologists. The pipeline could help expedite hematotoxicity assessment in preclinical studies and consequently could expedite drug development. The method may enable meta-analysis of rat bone marrow characteristics from future and historical whole slide images and may generate new biological insights from cross-study comparisons.